Skip to content
OpenCapital
Get started

Rapport Therapeutics, Inc. RAPP Q4 2025 Annual earnings

Reported March 10, 2026 · Before market open

Diluted EPS-$0.72Miss by $0.07
EPS estimate-$0.65

Next report

Aug 6, 2026 (in a month)
Revenue estimate$2.2M
EPS estimate-$0.96

Financials

Q4 2025

Income statement

See full
Operating income-$38.5M-63.7%
Net income-$33.8M-69.0%
EPS (diluted)-$0.71-492%

Balance sheet

See full
Cash & equivalents$52.6M-7.3%
Total debt$11.5M+678%
Total equity$484.7M+58.7%
Total assets$512.4M+62.7%

Cash flow

See full
Operating cash flow-$24.7M-71.0%
CapEx$169.0K-25.2%
Free cash flow-$24.9M-69.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.45B+123%
Enterprise value$1.4B+137%

Returns & leverage

See full
Return on equity-28.2%—
Debt / equity0×0.0×
Current ratio26.2×-9.2×

Versus estimates

Revenue

Q1 2026$20.0MBeat by $12.5M

Diluted EPS

Q1 2026-$0.42Beat by $0.14
Q4 2025-$0.72Miss by $0.07
Q3 2025-$0.71Beat by $0.06Q2 2025-$0.75Beat by $0.12Q1 2025-$0.68Beat by $0.09Q4 2024-$0.57Beat by $0.05

Ask the moment Rapport Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rapport Therapeutics, Inc. report Q4 2025 earnings?
Rapport Therapeutics, Inc. (RAPP) reported Q4 2025 earnings on March 10, 2026 before market open.
What were Rapport Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Rapport Therapeutics, Inc. reported diluted EPS of $-0.72 for Q4 2025.
Did Rapport Therapeutics, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.65 by $0.07.
How did Rapport Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 26.3% from $-0.57.
Where can I find Rapport Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-099336) and the 10-K periodic report (0001193125-26-099360) directly on SEC EDGAR. The filing index links above go to sec.gov.